Avicena Receives Drug Patent

Send Email

Acivena has announced the USPTO has granted a patent (#7,285,573) for use of their proprietary drug candidates to battle ALS (amyotrophic lateral sclerosis), otherwise known as Lou Gherig‘s disease. This patent joins an expanding portfolio of Acivena drugs for treating ALS, all aimed at slowing the disease’s progress and "improving the quality of life for patients."

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.medicaldevicepatentattorneys.com/2007/11/avicena-receives-drug-patent/trackback/
Send To A Friend Use this form to send this entry to a friend via email.